Humanigen Isn’t Throwing In The Towel On Lenzilumab For COVID-19 Just Yet

Humanigen announced preliminary results of a Phase III study of lenzilumab in COVID-19 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip